WASHINGTON, DC, December 2014 – Juggernaut Capital Partners (“JCP”), a private equity investor in middle market consumer products and business services companies, announced today that it has made an investment in Foundation Consumer Healthcare (“Foundation” or the “Company”), Foundation was formed to acquire and develop a portfolio of over-the-counter health and wellness brands.  Their current portfolio includes several well-known brands, namely Neo-Synephrine and BRONKAID, two OTC upper respiratory drugs, and St. Joseph low dose aspirin.